COMPOUND GUIDE 5 MIN READ

GLP-3RT: Research Overview and Mechanism

GLP-3RT is a research peptide studied as a triple agonist of the GIP, GLP-1, and glucagon receptors. In laboratory and preclinical research it is investigated within energy metabolism, glucose homeostasis, and adiposity endpoints. It is supplied as a lyophilized powder for research use only and is not approved for human use.

What makes GLP-3RT distinct

Most incretin research peptides target one or two receptors. GLP-3RT is studied as a triple agonist, engaging the GIP, GLP-1, and glucagon receptors simultaneously. This multi-receptor profile is why it is of particular interest as a tool compound in metabolic research.

Pathways it is studied within

Research using GLP-3RT examines insulin secretion and glucose homeostasis (via GLP-1 and GIP signaling) alongside energy expenditure and lipid handling (via glucagon-receptor signaling). Endpoints in preclinical models include glucose regulation and adiposity.

Beyond preclinical work, retatrutide has been investigated in the Phase 3 TRIUMPH clinical trial program as an investigational triple-receptor agonist, and it is not an approved drug. This describes the state of the research literature in the third person; it is not a human-use claim for the material supplied here, which is for laboratory research only.

Handling and documentation

Pinnacle GLP-3RT is supplied as a 20mg lyophilized vial of the triple-receptor agonist (molecular weight near 4731.3 g/mol). Because acylated peptides of this class can be offered in more than one salt form, the counterion and net peptide content should be reconciled against the lot-matched Certificate of Analysis before any molar calculation.

Store the vial at -20°C protected from light and reconstitute with bacteriostatic water added gently against the wall, avoiding the vigorous shaking that can stress an acylated peptide. Every batch is independently tested by HPLC and mass spectrometry, and the COA confirms both identity and purity.

All products are intended strictly for in-vitro laboratory research and development use only. Not for human or veterinary use, not a drug, food, or cosmetic, and not intended to diagnose, treat, cure, or prevent any disease.

Related research peptides

≥99% PURITYGLP-3RT 20mg research vial
METABOLIC RESEARCH

GLP-3RT 20mg

COA included, doctoral chemist tested

A next-generation triple-receptor agonist studied within metabolic, glucose-regulation, and energy-homeostasis research pathways.

from$199/ 20mg
FAQ

Frequently Asked Questions

What receptors does GLP-3RT target?

GLP-3RT is studied as a triple agonist of the GIP, GLP-1, and glucagon receptors. This multi-receptor profile is the focus of metabolic and glucose-regulation research using the compound.

What is GLP-3RT studied for in research?

In laboratory and preclinical research, GLP-3RT is studied within energy metabolism, glucose homeostasis, and adiposity endpoints. It is for research use only and is not approved for human use.

Source peptides you can verify

Doctoral chemist tested, 99% purity, with a Certificate of Analysis on every vial.